↓ Skip to main content

Cannabinoids for epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, March 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Citations

dimensions_citation
140 Dimensions

Readers on

mendeley
482 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cannabinoids for epilepsy
Published in
Cochrane database of systematic reviews, March 2014
DOI 10.1002/14651858.cd009270.pub3
Pubmed ID
Authors

David Gloss, Barbara Vickrey

Abstract

Marijuana appears to have anti-epileptic effects in animals. It is not currently known if it is effective in patients with epilepsy. Some states in the United States of America have explicitly approved its use for epilepsy.

Twitter Demographics

The data shown below were collected from the profiles of 33 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 482 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 1%
United Kingdom 2 <1%
Brazil 1 <1%
Puerto Rico 1 <1%
Peru 1 <1%
Unknown 472 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 102 21%
Researcher 66 14%
Student > Master 63 13%
Other 38 8%
Student > Ph. D. Student 37 8%
Other 90 19%
Unknown 86 18%
Readers by discipline Count As %
Medicine and Dentistry 144 30%
Pharmacology, Toxicology and Pharmaceutical Science 41 9%
Agricultural and Biological Sciences 37 8%
Psychology 33 7%
Neuroscience 32 7%
Other 87 18%
Unknown 108 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 153. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2022.
All research outputs
#210,494
of 22,053,897 outputs
Outputs from Cochrane database of systematic reviews
#350
of 12,174 outputs
Outputs of similar age
#1,921
of 201,703 outputs
Outputs of similar age from Cochrane database of systematic reviews
#8
of 199 outputs
Altmetric has tracked 22,053,897 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,174 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.9. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 201,703 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 199 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.